Differences in HRQOL among Children with SCD Who Received Hydroxyurea and Those Who Did Not: A Quantitative Comparison Study
Hydroxyurea improved the children's HRQOL compared to those who did not receive the drug. These findings support the use of hydroxyurea in children to improve HRQOL and reduce vaso-occlusive episodes. We recommend increasing parents' understanding of hydroxyurea's significance and devising strategies to promote children's medication adherence. It is essential to modify the SCD management protocol to optimize the HRQOL among children with SCD.
Authors
- Amal Al Sabahi
- Salah Thabit Al Awaidy (ORCID: https://orcid.org/0000-0001-5112-3893)
- Yusra Al Nasiri (ORCID: https://orcid.org/0000-0002-3993-9010)
- Shah Mohammed Wasifuddin
- Mudhar Al Adawi
- Kamla Al Nassri
- Mohammed Al Hanai
- Karima Al Hanai
- Nawal Al Mashayki
Institutions
- Oman Medical College (OM)
- Ministry of Health (OM)
- Sultan Qaboos University Hospital (OM)
Publication Details
- Journal
- Oman Medical Journal
- Published
- 2025-05-31
- DOI
- https://doi.org/10.5001/omj.2025.72
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00